Krystal Biotech, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $1.06B
Liabilities Breakdown FY2024
Total Liabilities: $109.5M
Asset Breakdown
Total Assets: $1.06B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $344.9M | 32.7% |
| Accounts Receivable | $104.7M | 9.9% |
| Inventory | $26.5M | 2.5% |
| Property, Plant & Equipment | $155.2M | 14.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $424.6M | 40.2% |
Liabilities Breakdown
Total Liabilities: $109.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.0M | 4.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $104.5M | 95.4% |